The world is currently experiencing a huge challenge which has affected all the industries and markets. Few markets have experienced a high growth in their demand while others have faced a downfall. The extent of growth or drop in the market statistics of different industries by COVID 19 plays an important role in how the future of businesses will shape up in the near future. We at Value Market Research provide you with an impact analysis of COVID 19 on this market with its latest update in the purchased version of the report.
Global Nucleic Acid Drugs Market Report By Type (Antisense Nucleic Acid Drugs, SiRNA Drugs, SaRNA Drugs, MiRNA Drugs, MRNA Drugs, Other), By Application (Genetic Disease, Cancer, Cardiovascular Diseases, Other) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028
ID:VMR11219747
November 2022
Report Formats: Electronic (PDF), MS EXCEL
The global demand for Nucleic Acid Drugs Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
Nucleic acid drugs are the next-generation drugs with tremendous potential to cure various life-threatening human diseases such as genetic disorders, cancer, rare diseases, and viral infections. Nucleic acid drugs offer novel therapeutic methods. With the help of nucleotide sequence information, nucleic acid drugs regulate the biological function of the cell. Nucleic acid drugs can reach biological targets where traditional drugs could not act. This unique property makes nucleic acid drugs more effective than other traditional drugs and enhances their ability to cure diseases. They can target disorders at the genetic level. The key ingredients of nucleic acid drugs include chemically synthesized oligonucleotides and tiny molecules.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of nucleic acid drugs. The growth and trends of nucleic acid drugs industry provide a holistic approach to this study.
By Type
By Application
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the nucleic acid drugs market include Sarepta Therapeutics, Ionis Pharmaceuticals, Alnylam, Mina Therapeutics, BioNTech, NeXstar Pharmaceuticals, Nippon Shinyaku, Moderna Therapeutics, CureVac, Regulus Therapeutics, Miragen Therapeutics. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
Nucleic acid drugs are the next-generation drugs with tremendous potential to cure various life-threatening human diseases such as genetic disorders, cancer, rare diseases, and viral infections. Nucleic acid drugs offer novel therapeutic methods. With the help of nucleotide sequence information, nucleic acid drugs regulate the biological function of the cell. Nucleic acid drugs can reach biological targets where traditional drugs could not act. This unique property makes nucleic acid drugs more effective than other traditional drugs and enhances their ability to cure diseases. They can target disorders at the genetic level. The key ingredients of nucleic acid drugs include chemically synthesized oligonucleotides and tiny molecules.
Market Dynamics
The global nucleic acid drug market is mainly driven by the rising prevalence of genetic disorders and other life-threatening human diseases and the growing demand for treating diseases at the genetic level. Besides the nucleic acid drugs market is fuelled by increasing awareness about the benefits of nucleic acid drugs, growing healthcare expenditure, increasing investments in R &D, and technological advancement in healthcare infrastructure. However, high costs, side effects caused by nucleic acid drugs, and introduction of the generic drugs may hamper the global market.The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of nucleic acid drugs. The growth and trends of nucleic acid drugs industry provide a holistic approach to this study.
Market Segmentation
This section of the nucleic acid drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.By Type
- Antisense Nucleic Acid Drugs
- SiRNA Drugs
- SaRNA Drugs
- MiRNA Drugs
- MRNA Drugs
- Other
By Application
- Genetic Disease
- Cancer
- Cardiovascular Diseases
- Other
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Nucleic Acid Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.Global Nucleic Acid Drugs Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the nucleic acid drugs market include Sarepta Therapeutics, Ionis Pharmaceuticals, Alnylam, Mina Therapeutics, BioNTech, NeXstar Pharmaceuticals, Nippon Shinyaku, Moderna Therapeutics, CureVac, Regulus Therapeutics, Miragen Therapeutics. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . NUCLEIC ACID DRUGS – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Type
3.7.2 Market Attractiveness Analysis By Application
3.7.3 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
5.1. Impact Analysis of Covid-19 Outbreak
5.1.1. Direct Impact on Production
5.1.2. Supply Chain and Market Disruption
5.1.3. Financial Impact on Firms and Financial Markets
5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
5.3. Market: Pre V/S Post COVID-19
5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
5.5. COVID-19: Micro and Macro Factor Analysis
6 . GLOBAL NUCLEIC ACID DRUGS MARKET ANALYSIS BY TYPE
6.1 Overview by Type
6.2 Historical and Forecast Data
6.3 Analysis by Type
6.4 Antisense Nucleic Acid Drugs Historic and Forecast Sales by Regions
6.5 SiRNA Drugs Historic and Forecast Sales by Regions
6.6 SaRNA Drugs Historic and Forecast Sales by Regions
6.7 MiRNA Drugs Historic and Forecast Sales by Regions
6.8 MRNA Drugs Historic and Forecast Sales by Regions
6.9 Other Historic and Forecast Sales by Regions
7 . GLOBAL NUCLEIC ACID DRUGS MARKET ANALYSIS BY APPLICATION
7.1 Overview by Application
7.2 Historical and Forecast Data
7.3 Analysis by Application
7.4 Genetic Disease Historic and Forecast Sales by Regions
7.5 Cancer Historic and Forecast Sales by Regions
7.6 Cardiovascular Diseases Historic and Forecast Sales by Regions
7.7 Other Historic and Forecast Sales by Regions
8 . GLOBAL NUCLEIC ACID DRUGS MARKET ANALYSIS BY GEOGRAPHY
8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
8.3.1. Overview, Historic and Forecast Sales Analysis
8.3.2. North America By Segment Sales Analysis
8.3.3. North America By Country Sales Analysis
8.3.4. United State Sales Analysis
8.3.5. Canada Sales Analysis
8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
8.4.1. Overview, Historic and Forecast Sales Analysis
8.4.2. Europe by Segment Sales Analysis
8.4.3. Europe by Country Sales Analysis
8.4.4. United Kingdom Sales Analysis
8.4.5. France Sales Analysis
8.4.6. Germany Sales Analysis
8.4.7. Italy Sales Analysis
8.4.8. Russia Sales Analysis
8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
8.5.1. Overview, Historic and Forecast Sales Analysis
8.5.2. Asia Pacific by Segment Sales Analysis
8.5.3. Asia Pacific by Country Sales Analysis
8.5.4. China Sales Analysis
8.5.5. India Sales Analysis
8.5.6. Japan Sales Analysis
8.5.7. South Korea Sales Analysis
8.5.8. Australia Sales Analysis
8.5.9. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
8.6.1. Overview, Historic and Forecast Sales Analysis
8.6.2. Latin America by Segment Sales Analysis
8.6.3. Latin America by Country Sales Analysis
8.6.4. Brazil Sales Analysis
8.6.5. Argentina Sales Analysis
8.6.6. Peru Sales Analysis
8.6.7. Chile Sales Analysis
8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
8.7.1. Overview, Historic and Forecast Sales Analysis
8.7.2. Middle East & Africa by Segment Sales Analysis
8.7.3. Middle East & Africa by Country Sales Analysis
8.7.4. Saudi Arabia Sales Analysis
8.7.5. UAE Sales Analysis
8.7.6. Israel Sales Analysis
8.7.7. South Africa Sales Analysis
8.7.8. Rest Of Middle East And Africa Sales Analysis
9 . COMPETITIVE LANDSCAPE OF THE NUCLEIC ACID DRUGS COMPANIES
9.1. Nucleic Acid Drugs Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments
10 . COMPANY PROFILES OF NUCLEIC ACID DRUGS INDUSTRY
10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Sarepta Therapeutics
10.3.1. Company Overview
10.3.2. Company Revenue
10.3.3. Products
10.3.4. Recent Developments
10.4. Ionis Pharmaceuticals
10.4.1. Company Overview
10.4.2. Company Revenue
10.4.3. Products
10.4.4. Recent Developments
10.5. Alnylam
10.5.1. Company Overview
10.5.2. Company Revenue
10.5.3. Products
10.5.4. Recent Developments
10.6. Mina Therapeutics
10.6.1. Company Overview
10.6.2. Company Revenue
10.6.3. Products
10.6.4. Recent Developments
10.7. BioNTech
10.7.1. Company Overview
10.7.2. Company Revenue
10.7.3. Products
10.7.4. Recent Developments
10.8. NeXstar Pharmaceuticals
10.8.1. Company Overview
10.8.2. Company Revenue
10.8.3. Products
10.8.4. Recent Developments
10.9. Nippon Shinyaku
10.9.1. Company Overview
10.9.2. Company Revenue
10.9.3. Products
10.9.4. Recent Developments
10.10. Moderna Therapeutics
10.10.1. Company Overview
10.10.2. Company Revenue
10.10.3. Products
10.10.4. Recent Developments
10.11. CureVac
10.11.1. Company Overview
10.11.2. Company Revenue
10.11.3. Products
10.11.4. Recent Developments
10.12. Regulus Therapeutics
10.12.1. Company Overview
10.12.2. Company Revenue
10.12.3. Products
10.12.4. Recent Developments
10.13. Miragen Therapeutics
10.13.1. Company Overview
10.13.2. Company Revenue
10.13.3. Products
10.13.4. Recent Developments
*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers : Impact Analysis
- Restraints : Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- COVID-19 Impact Analysis by Production, Import, Export and Demand
- Pre V/S Post COVID-19
- Estimated Impact Of The Coronavirus (Covid-19) Epidemic
- COVID-19: Micro and Macro Factor Analysis
- Analysis by Type (USD MN)
- Antisense Nucleic Acid Drugs Market Sales by Geography (USD MN)
- SiRNA Drugs Market Sales by Geography (USD MN)
- SaRNA Drugs Market Sales by Geography (USD MN)
- MiRNA Drugs Market Sales by Geography (USD MN)
- MRNA Drugs Market Sales by Geography (USD MN)
- Other Market Sales by Geography (USD MN)
- Analysis Market by Application (USD MN)
- Genetic Disease Market Sales by Geography (USD MN)
- Cancer Market Sales by Geography (USD MN)
- Cardiovascular Diseases Market Sales by Geography (USD MN)
- Other Market Sales by Geography (USD MN)
- Global Nucleic Acid Drugs Market Sales by Geography (USD MN)
- North America Market Analysis (USD MN)
- United State Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate by Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of Nucleic Acid Drugs Report
- Market Research Process
- Market Research Methodology
- Global Nucleic Acid Drugs Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Type
- Market Attractiveness Analysis by Application
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Market Analysis by Type (USD MN)
- Antisense Nucleic Acid Drugs Market Sales by Geography (USD MN)
- SiRNA Drugs Market Sales by Geography (USD MN)
- SaRNA Drugs Market Sales by Geography (USD MN)
- MiRNA Drugs Market Sales by Geography (USD MN)
- MRNA Drugs Market Sales by Geography (USD MN)
- Other Market Sales by Geography (USD MN)
- Global Market Analysis by Application (USD MN)
- Genetic Disease Market Sales by Geography (USD MN)
- Cancer Market Sales by Geography (USD MN)
- Cardiovascular Diseases Market Sales by Geography (USD MN)
- Other Market Sales by Geography (USD MN)
- Global Market by Revenue
- North America Market by Revenue
- Europe Market by Revenue
- Asia Pacific Market by Revenue
- Latin America Market by Revenue
- Middle East & Africa Market by Revenue
- Recent Development in Industry
- Top Companies Market Share Analysis
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
Related Categories
Pharmaceuticals
Buy Chapters or Sections
Avail customized purchase options to meet your exact research needs:
- Buy sections of this report
- Buy country level reports
- Request for historical data
- Request discounts available for Start-Ups & Universities
Objectives of Study
- Define and measure the global market
- Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
- Analyze and identify major market trends along with the factors driving or inhibiting the market growth
- Study the company profiles of the major market players with their market share
- Analyze competitive developments